Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI Palantir Fixed Tech100 Index (KPLTT100)
3/20/2026, 12:00:00 AM
Biogen and partner Eisai presented new real-world data on March 20, 2026, at the AD/PD™ 2026 conference, showing high long-term treatment persistence for Leqembi, with 67.3% of patients remaining on therapy at 24 months. This event is estimated to have a low impact as it reinforces existing clinical data.
Korean Translation
2026년 3월 20일, 바이오젠과 파트너사 에자이는 AD/PD™ 2026 컨퍼런스에서 레켐비의 높은 장기 치료 지속성을 보여주는 새로운 실제 임상 근거(real-world data)를 발표했으며, 24개월 시점에 환자의 67.3%가 치료를 유지함. 기존 데이터 강화 수준으로 낮은 영향이 예상됨.
Related Recent Events
Micron Technology Inc. (MU) · Earnings Release
Micron's fiscal third-quarter 2026 earnings release is scheduled for June 24, 2026, scheduled. High importance is estimated as earnings releases for major semiconductor companies typically result in price impacts exceeding 10%.
6/24/2026, 12:00:00 AM
Apple Inc (AAPL) · Other
Apple's annual Worldwide Developers Conference (WWDC) is scheduled to begin on June 8, 2026, to unveil iOS 27 and major AI advancements; these updates are estimated to have a >5% price impact scheduled
6/8/2026, 12:00:00 AM
Palo Alto Networks Inc (PANW) · Earnings Release
Palo Alto Networks' next earnings release for Q3 2026 is scheduled for May 19, 2026. Low importance as it is a routine scheduled announcement with no results yet, scheduled.
5/19/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Next earnings release for Q1 2026 is scheduled for 2026-05-14, with analysts forecasting an EPS of -$0.04. A neutral impact is expected as the market typically waits for actual results, so the release is forecasted and scheduled.
5/14/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q1 2026 earnings release is scheduled. Analysts forecast EPS of $3.41. Medium importance is estimated as earnings releases typically drive significant volatility scheduled.
5/13/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q1 2026 earnings release scheduled for May 5, 2026. The company guided for Q1 revenue of approximately $9.8 billion, representing ~32% year-over-year growth but a sequential decline. Analysts forecast EPS of ~$1.27. Medium market impact as a major quarterly catalyst expected.
5/5/2026, 12:00:00 AM